StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) in a research note issued on Monday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Stock Performance
NASDAQ CPIX opened at $1.22 on Monday. The company has a fifty day moving average of $1.38 and a two-hundred day moving average of $1.53. The company has a market capitalization of $17.31 million, a PE ratio of -2.07 and a beta of 0.20. Cumberland Pharmaceuticals has a 1 year low of $1.22 and a 1 year high of $2.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.44 and a quick ratio of 1.26.
About Cumberland Pharmaceuticals
Featured Articles
- Five stocks we like better than Cumberland Pharmaceuticals
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Learn Technical Analysis Skills to Master the Stock Market
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.